Registration now live for SMi's 12th annual Asthma & COPD conference and exhibition

Top Quote SMi Group Reports : Its 12th annual conference on Asthma & COPD will be held in London on the 11th - 12th April 2016. End Quote
  • (1888PressRelease) November 27, 2015 - Respiratory diseases represent an enormous and increasing healthcare and economic burden across Europe and USA.

    Over the last few years, significant improvements in the management of asthma and COPD have been made, owing to new drugs, strategies and to the development of the nonpharmacologic treatment of COPD. Nevertheless, there are still many unmet needs in the treatment of these diseases.

    The conference will explore innovative asthma and COPD drug development programmes, directives and procedures which have been put in place to reduce the enormous suffering from lung disease and its high mortality.

    Keynote speakers for 2016 include:
    (Chairman) - Ewan Walters, Medical Director, Teva UK
    Peter Daley-Yates, Director Clinical Pharmacology, GSK
    Andy Kenwright, Senior Statistical Scientist, Roche Pharma
    Jan Olof Svensson, Principal Scientist, AstraZeneca
    Roland Kolbeck, Senior Director, MedImmune
    Nayna Govind, Director for the Development of Generic Inhalation Products, Dr. Reddy's Laboratories
    Konstantinos Kostikas, Medical Director Respiratory, Novartis

    For more information, to review the full agenda or to register please visit the event website at www.asthma-copd.co.uk/1888pressrelease

    Highlights of Asthma & COPD 2016 include:
    Discuss the challenges for generic inhalation products for EU and US markets
    Gain insight into scientific aspects of quality regulations in respiratory drug development
    Review innate lymphocytes (ILC) in COPD
    Learn about "first in class" inhaled drugs for the treatment of COPD and cystic fibrosis
    Explore corticosteroid insensitivity in severe asthma
    Study formulation and process of inhaled products
    Analyse clinical development of generic

    In addition to the conference, the event will feature 2 interactive half-day post-conference workshops held on the 13th April 2016.
    1. Human factors and inhaler handling studies
    Workshop Leader: Stefan Leiner, Chemical - Pharmaceutical Expert, Boehringer Ingelheim
    2. Pragmatic compliance remediation - how to get your marketed product into shape?
    Workshop Leader: Mark Chipperfield, Principal Consultant, Corvus Device Limited

    For more information or to register visit the event website at www.asthma-copd.co.uk/1888pressrelease

    To take advantage of the EARLY BIRD OFFER register before the 18th December 2015 to save 400 off the conference price.

    For delegate enquiries contact Matthew Apps +44 (0) 20 7827 6093 or email mapps ( @ ) smi-online dot co dot uk

    For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick ( @ ) smi-online dot co dot uk

    For media enquiries contact Anna Serazetdinova on +44 (0) 20 7827 6180 or email aserazetdinova ( @ ) smi-online dot co dot uk

    12th annual Asthma & COPD conference and exhibition
    11th - 12th April 2016
    London, UK
    Contact e-mail: aserazetdinova ( @ ) smi-online dot co dot uk
    Contact number: +44 (0) 20 7827 6093
    Event Website: www.asthma-copd.co.uk/1888pressrelease

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information